Joel Armotrading
GTD
Injury Chest
2025 CBB Stats
PTS
6.1
REB
5.1
AST
0.4
STL
0.4
BLK
1.3
ROS Projections
Undergoes medical imaging
Armotrading (chest) underwent medical imaging Tuesday, according to Dominic Gutierrez of SB Nation.
ANALYSIS
Considering the medical imaging, Armotrading unsurprisingly did not play during Nevada's latest game Tuesday against San Diego State. So once again, Kaleb Lowery logged another start. The medical test's result remains publicly unknown.
Considering the medical imaging, Armotrading unsurprisingly did not play during Nevada's latest game Tuesday against San Diego State. So once again, Kaleb Lowery logged another start. The medical test's result remains publicly unknown.
College Basketball Stats
Loading CBB Stats...
2023 CBB Game Log
2025
2024
2023
2025 CBB Game Log
Loading Game Log...
2025 CBB Split Stats
Loading CBB Stats...
Wolf Pack Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Given questionable tag again
Armotrading (chest) is questionable for Tuesday's game against San Diego State.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Doesn't play Saturday
Armotrading (chest) didn't play Saturday against Fresno State.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Game-time call Saturday
Armotrading (chest) is a game-time decision for Nevada's clash with Fresno State on Saturday.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Questionable for Saturday
Armotrading (chest) is questionable for Saturday's game against Fresno State.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Sits out Tuesday
Armotrading (chest) sat out during Tuesday's 75-62 win over CSU.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.